Abstract:This study involved the design and synthesis of 21 new nitrogen-containing heterocyclic chalcone derivatives utilizing the active substructure splicing principle, with glycyrrhiza chalcone serving as the lead compound. The targets of these derivatives were VEGFR-2 and P-gp, and their efficacy against cervical cancer was evaluated. Following preliminary conformational analysis, compound 6f ((E)-1-(2-hydroxy-5-((4-hydroxypiperidin-1-yl)methyl)-4-methoxyphenyl)-3-(4-((4-methylpiperidin-1-yl)methyl)phenyl)prop-2-en-1-one) exhibited significant antiproliferative activity against human cervical cancer cells (HeLa and SiHa) with IC50 values of 6.52 ± 0.42 and 7.88 ± 0.52 μM, respectively, when compared to other compounds and positive control drugs. Additionally, this compound demonstrated lower toxicity towards human normal cervical epithelial cells (H8). Subsequent investigations have demonstrated that 6f exerts an inhibitory impact on VEGFR-2, as evidenced by its ability to impede the phosphorylation of p-VEGFR-2, p-PI3K, and p-Akt proteins in HeLa cells. This, in turn, results in the suppression of cell proliferation and the induction of both early and late apoptosis in a concentration-dependent manner. Furthermore, 6f significantly curtails the invasion and migration of HeLa cells. In addition, 6f had an IC50 of 7.74 ± 0.36 μM against human cervical cancer cisplatin-resistant HeLa/DDP cells and a resistance index (RI) of 1.19, compared to 7.36 for cisplatin HeLa cells. The combination of 6f and cisplatin resulted in a significant reduction in cisplatin resistance in HeLa/DDP cells. Molecular docking analyses revealed that 6f exhibited binding free energies of −9.074 and −9.823 kcal·mol−1 to VEGFR-2 and P-gp targets, respectively, and formed hydrogen bonding forces. These findings suggest that 6f has potential as an anti-cervical cancer agent and may reverse cisplatin-resistant activity in cervical cancer. The introduction of the 4-hydroxy piperidine and 4-methyl piperidine rings may contribute to its efficacy, and its mechanism of action may involve dual inhibition of VEGFR-2 and P-gp targets.

Design,Synthesis and Anti-cervical Cancer Activity of Piperine-bicycloamide Derivatives

Design, Synthesis, and Antiproliferative Evaluation of Piperine Derivatives

Design, Synthesis and Biological Evaluation of Piperine Derivatives As Potent Antitumor Agents

Design, synthesis, and evaluation of benzodioxolane compounds for antitumor activity

Synthesis and antiproliferative evaluation of new hybrids of piperine and acylhydrazone

Design, Synthesis and In‐Silico Studies of Piperidine‐Dihydropyridine Hybrids as Anticancer Agents

Alkaloids from Piper Longum Exhibit Anti-inflammatory Activity and Synergistic Effects with Chemotherapeutic Agents Against Cervical Cancer Cells

Design, Synthesis, and Anti-Cervical Cancer and Reversal of Tumor Multidrug Resistance Activity of Novel Nitrogen-Containing Heterocyclic Chalcone Derivatives

Synthesis and Antitumor Activity of Tetrahydroimidazo[2′,1′:2,3]thiazolo [5,4-C]piperdine Derivatives

Design, Synthesis and Biological Activity of Piperlongumine Derivatives As Selective Anticancer Agents.

Synthesis and Biological Evaluation of Piperazine Group-Linked Bivalent Beta-Carbolines As Potential Antitumor Agents

SYNTHESIS AND ANTI-TUMOR ACTIVITIES OF 1,4 BIS[3- (AMINO-DITHIOCARBOXY)PROPIONYL] PIPERAZINE DERIVATIVES

Synthesis and anti-tumor activity of 1-［bi-(4-fluoroph enyl)-methyl］-4-substituted piperazines Synthesis and anti-tumor activity of 1-［bi-(4-fluoroph enyl)-methyl］-4-substituted piperazines

Design, synthesis and antitumor activity evaluation of pyrimidine derivatives containing 4-hydroxypiperidine group

Synthesis Of Diaryl Ether Substituted Piperazine Derivatives And Their Cytotoxic Activities

Design, Synthesis, and Biological Evaluation of Matrine Derivatives Possessing Piperazine Moiety As Antitumor Agents

Design, Synthesis and Preliminary Biological Evaluation of 5,8-Dihydropteridine-6,7-diones That Induce Apoptosis and Suppress Cell Migration

Synthesis and Antitumor Activity of Novel N-(5-Benzyl-4-(Tert-Butyl)Thiazol-2-Yl)-2-(Piperazin-1-Yl)Acetamides

Synthesis and Antitumor Activities of Piperazine- and Cyclen-Conjugated Dehydroabietylamine Derivatives

Synthesis and Cytotoxic Activity of Novel Hybrid Compounds Between Piperonyl and Imidazolium Salts

Design, Synthesis and Anticancer Activity of a New Series of <i>N</i>-aryl-<i>N</i>-[4-(pyridin-2-ylmethoxy)benzyl]urea Derivatives